Literature DB >> 29617667

Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.

Michael Seiler1, Shouyong Peng1, Anant A Agrawal1, James Palacino1, Teng Teng1, Ping Zhu1, Peter G Smith1, Silvia Buonamici2, Lihua Yu3.   

Abstract

Hotspot mutations in splicing factor genes have been recently reported at high frequency in hematological malignancies, suggesting the importance of RNA splicing in cancer. We analyzed whole-exome sequencing data across 33 tumor types in The Cancer Genome Atlas (TCGA), and we identified 119 splicing factor genes with significant non-silent mutation patterns, including mutation over-representation, recurrent loss of function (tumor suppressor-like), or hotspot mutation profile (oncogene-like). Furthermore, RNA sequencing analysis revealed altered splicing events associated with selected splicing factor mutations. In addition, we were able to identify common gene pathway profiles associated with the presence of these mutations. Our analysis suggests that somatic alteration of genes involved in the RNA-splicing process is common in cancer and may represent an underappreciated hallmark of tumorigenesis.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FUBP1; RBM10; SF3B1; SRSF2; U2AF1; cancer; mutation; splicing

Mesh:

Substances:

Year:  2018        PMID: 29617667      PMCID: PMC5933844          DOI: 10.1016/j.celrep.2018.01.088

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  66 in total

1.  Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.

Authors:  L He; J Liu; I Collins; S Sanford; B O'Connell; C J Benham; D Levens
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Genomic Characterization of Primary Invasive Lobular Breast Cancer.

Authors:  Christine Desmedt; Gabriele Zoppoli; Gunes Gundem; Giancarlo Pruneri; Denis Larsimont; Marco Fornili; Debora Fumagalli; David Brown; Françoise Rothé; Delphine Vincent; Naima Kheddoumi; Ghizlane Rouas; Samira Majjaj; Sylvain Brohée; Peter Van Loo; Patrick Maisonneuve; Roberto Salgado; Thomas Van Brussel; Diether Lambrechts; Ron Bose; Otto Metzger; Christine Galant; François Bertucci; Martine Piccart-Gebhart; Giuseppe Viale; Elia Biganzoli; Peter J Campbell; Christos Sotiriou
Journal:  J Clin Oncol       Date:  2016-02-29       Impact factor: 44.544

3.  Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.

Authors:  Mrinal M Patnaik; Terra L Lasho; Christy M Finke; Curtis A Hanson; Janice M Hodnefield; Ryan A Knudson; Rhett P Ketterling; Animesh Pardanani; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2013-01-18       Impact factor: 10.047

4.  SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.

Authors:  Eunhee Kim; Janine O Ilagan; Yang Liang; Gerrit M Daubner; Stanley C-W Lee; Aravind Ramakrishnan; Yue Li; Young Rock Chung; Jean-Baptiste Micol; Michele E Murphy; Hana Cho; Min-Kyung Kim; Ahmad S Zebari; Shlomzion Aumann; Christopher Y Park; Silvia Buonamici; Peter G Smith; H Joachim Deeg; Camille Lobry; Iannis Aifantis; Yorgo Modis; Frederic H-T Allain; Stephanie Halene; Robert K Bradley; Omar Abdel-Wahab
Journal:  Cancer Cell       Date:  2015-05-11       Impact factor: 31.743

5.  Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

Authors:  Jennifer D Hintzsche; Nicholas T Gorden; Carol M Amato; Jihye Kim; Kelsey E Wuensch; Steven E Robinson; Allison J Applegate; Kasey L Couts; Theresa M Medina; Keith R Wells; Joshua A Wisell; Martin D McCarter; Neil F Box; Yiqun G Shellman; Rene C Gonzalez; Karl D Lewis; John J Tentler; Aik Choon Tan; William A Robinson
Journal:  Melanoma Res       Date:  2017-06       Impact factor: 3.599

6.  Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.

Authors:  Jiawei Zhao; Yue Sun; Yin Huang; Fan Song; Zengshu Huang; Yufang Bao; Ji Zuo; David Saffen; Zhen Shao; Wen Liu; Yongbo Wang
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

7.  Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

8.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

9.  Comprehensive molecular profiling of lung adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

10.  Mutational landscape of RNA-binding proteins in human cancers.

Authors:  Yaseswini Neelamraju; Abel Gonzalez-Perez; Poornima Bhat-Nakshatri; Harikrishna Nakshatri; Sarath Chandra Janga
Journal:  RNA Biol       Date:  2017-11-14       Impact factor: 4.652

View more
  138 in total

1.  PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities.

Authors:  Shilpa Nadimpalli Kobren; Bernard Chazelle; Mona Singh
Journal:  Cell Syst       Date:  2020-07-14       Impact factor: 10.304

Review 2.  Altered RNA Processing in Cancer Pathogenesis and Therapy.

Authors:  Esther A Obeng; Connor Stewart; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2019-10-14       Impact factor: 39.397

Review 3.  Therapeutic approaches to treat human spliceosomal diseases.

Authors:  Anthony B DeNicola; Yi Tang
Journal:  Curr Opin Biotechnol       Date:  2019-02-15       Impact factor: 9.740

Review 4.  Identifying Epistasis in Cancer Genomes: A Delicate Affair.

Authors:  Joris van de Haar; Sander Canisius; Michael K Yu; Emile E Voest; Lodewyk F A Wessels; Trey Ideker
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

Review 5.  Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation.

Authors:  Yongsheng Li; Daniel J McGrail; Juan Xu; Gordon B Mills; Nidhi Sahni; Song Yi
Journal:  Trends Biochem Sci       Date:  2018-06-22       Impact factor: 13.807

6.  Splicing factor DHX15 affects tp53 and mdm2 expression via alternate splicing and promoter usage.

Authors:  John McElderry; Blake Carrington; Kevin Bishop; Erika Kim; Wuhong Pei; Zelin Chen; Ramanagouda Ramanagoudr-Bhojappa; Anupam Prakash; Shawn M Burgess; P Paul Liu; Raman Sood
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

Review 7.  Structural and functional modularity of the U2 snRNP in pre-mRNA splicing.

Authors:  Clarisse van der Feltz; Aaron A Hoskins
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-11-20       Impact factor: 8.250

8.  Aberrant RNA Splicing in Cancer.

Authors:  Luisa Escobar-Hoyos; Katherine Knorr; Omar Abdel-Wahab
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

9.  A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.

Authors:  Víctor Faundes; Geraldine Malone; William G Newman; Siddharth Banka
Journal:  J Hum Genet       Date:  2018-11-20       Impact factor: 3.172

10.  A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.

Authors:  Nikhil Wagle; Rachel A Freedman; Sara M Balch; Ines Vaz-Luis; Tianyu Li; Nabihah Tayob; Esha Jain; Karla Helvie; Jorge E Buendia-Buendia; Erin Shannon; Steven J Isakoff; Nadine M Tung; Ian E Krop; Nancy U Lin
Journal:  Breast Cancer Res Treat       Date:  2021-07-24       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.